Amidst a backdrop of renewed uncertainty about U.S. trade policy and escalating geopolitical tensions in the Middle East, European markets have seen declines, with the pan-European STOXX Europe 600 ...

Amid escalating geopolitical tensions and renewed uncertainty about U.S. trade policy, the European markets have experienced a downturn, with major indexes like Germany’s DAX and Italy’s FTSE MIB ...

As the European market experiences a positive shift, with the pan-European STOXX Europe 600 Index climbing 0.90% amid eased monetary policy from the European Central Bank and slowing inflation, ...

Rising momentum of operator-led start-ups, raising more funding with higher valuations, reshaping the start-up ecosystem.

OneSource Specialty Pharma partners with Xbrane Biopharma for biosimilar manufacturing, aiming to strengthen global supply ...

Around 12 p.m. both benchmark indices, Sensex and Nifty were trading higher. Nifty 50 was up 0.13% at 25,138 and Sensex was ...

Onesource Specialty Pharma advanced 1.55% to Rs 2057 after the company announced a partnership with Sweden-based Xbrane Biopharma AB for manufacturing biosimilars for global markets.

OneSource Specialty Pharma and Xbrane Biopharma AB, a Sweden-headquartered biotechnology company, today announced a partnership focused on the commercial manufacturing of Xbrane's biosimilar portfolio ...

On Tuesday, 2233 stocks advanced, 1800 declined and 134 remained unchanged on Bombay Stock Exchange with advance decline ratio of 1.24 indicating a positive closing in the broader market.